What Is an Infusion Port and What to Expect

An infusion port, often called a port-a-cath or simply a “port,” is a small medical device implanted under your skin to provide repeated, reliable access to your bloodstream. It consists of a quarter-sized reservoir with a self-sealing rubber top (the septum) connected to a thin tube (catheter) that threads into a large central vein near your heart. Ports are most commonly placed in people undergoing chemotherapy, but they also serve anyone who needs frequent IV medications, blood draws, or long-term nutrition delivered directly into the bloodstream. The device sits entirely beneath your skin, which sets it apart from other central lines and shapes much of the day-to-day experience of living with one.

What a Port Looks Like and How It Is Built

If you ran your fingers over the upper chest of someone with a port, you would feel a firm bump roughly the size and thickness of a large coin. Beneath the skin sits a titanium or plastic chamber about 2.5 to 3 centimeters across, with a thick silicone disc on top called the septum. That septum is compressed tightly enough to reseal itself after thousands of needle punctures over the device’s lifetime. A silicone or polyurethane catheter exits the chamber and runs through a vein, with its tip resting in the superior vena cava or at the junction where it meets the right atrium. Because the tip sits in a high-flow vessel, infused medications get diluted and distributed quickly, which is why chemotherapy drugs that would damage smaller peripheral veins can be delivered safely through a port.

Most ports have a single chamber and a single catheter lumen, but double-lumen versions exist for patients who need two separate infusions running at the same time. The tradeoff is worth knowing about: studies comparing the two designs consistently find that double-lumen ports carry higher rates of bloodstream infection, malfunction, fibrin sheath formation, and catheter-related clotting. One analysis found double-lumen chest ports had roughly three times the hazard rate for developing a bloodstream infection compared to single-lumen ports.1PubMed. A comparative analysis of infection and complication rates between single- and double-lumen ports A separate propensity-matched study reported about twice the infection rate per 1,000 catheter-days with double-lumen devices.2PubMed. Comparison of Infection Rates between Single-Lumen and Double-Lumen Chest Ports among Patients with Cancer: A Propensity Score Matching Analysis For most patients, a single-lumen port handles everything that is needed. Double-lumen devices are typically reserved for complex treatment regimens where simultaneous incompatible infusions are genuinely necessary.

The Placement Procedure

Port implantation is a minor procedure, usually performed by an interventional radiologist or surgeon and typically taking around 30 to 60 minutes. You will generally receive conscious sedation along with local anesthesia at the insertion site, so you are awake but relaxed and numb. The physician uses ultrasound to locate and access a large vein, often the internal jugular vein in the neck, and threads the catheter through it until the tip reaches the correct position near the heart. Fluoroscopy (real-time X-ray) confirms the catheter tip is in the right spot.3PubMed. Radiologic placement of subcutaneous infusion chest ports for long-term central venous access

A small pocket is then created under the skin of the upper chest, and the port reservoir is tucked into it. The catheter is tunneled under the skin from the vein entry point down to the pocket and connected to the reservoir. The incisions are closed with sutures or adhesive strips, and a dressing is placed over the site. Most people go home the same day. Soreness around the implant site is normal for a week or two, and you will be told to avoid heavy lifting or vigorous upper-body activity while the pocket heals. The small bump under the skin becomes your permanent access point.

While the chest is the traditional placement site, ports can also be implanted in the upper arm, an option that has gained attention particularly in breast cancer care. An arm port avoids adding a scar to the chest, which can matter for patients who have already undergone breast surgery. Studies on arm-port placement report high patient satisfaction and no negative impact on quality of life, with most patients saying they would choose the device again if needed.4PubMed. Satisfaction and Quality of Life Related to Chemotherapy With an Arm Port: A Pilot Study Research on breast cancer patients specifically highlights that an arm placement avoids additional chest scars and offers cosmetic and psychological advantages.5PubMed Central. Impact of totally implanted venous access port placement on body image in women with breast cancer

How a Port Gets Accessed

When it is time for a treatment or blood draw, a nurse cleans the skin over the port and inserts a special non-coring needle through the skin and through the septum. Non-coring needles, sometimes called Huber needles, have a tip shaped to slice through silicone without removing a tiny core of material the way a regular needle would. This design is what allows the septum to reseal itself time after time.6PubMed. Clinical experiences of using ports and non-coring needles The needle is taped in place with a transparent dressing during the infusion, and when treatment is done, the needle is removed and the port goes back to being invisible under the skin.

For many people, the needle stick is the part they dread most. The sensation is often described as a quick, firm poke through the skin into a hard surface. Over time, the skin above the port can develop a bit of numbness, which makes it more tolerable. But for those who find it painful, topical numbing creams make a real difference. EMLA cream, a mix of two local anesthetics, has been studied extensively for port access. In children with cancer, applying EMLA before port puncture led to statistically significant decreases in pain scores compared to a placebo.7Journal of Pain and Symptom Management. Trial of a topically administered local anesthetic (EMLA cream) for pain relief during central venous port accesses in children with cancer A study in adults found similar benefits, with patients who used EMLA reporting substantially lower pain levels during port needle insertion.8PubMed. Evaluation of EMLA cream for relieving pain during needle insertion on totally implantable venous access device Another topical anesthetic, amethocaine gel, achieves comparable numbing with a shorter application time, which can be convenient when appointment schedules are tight.9Pediatrics. Relative Efficacy of Amethocaine Gel and Lidocaine–Prilocaine Cream for Port-a-Cath Puncture in Children If you have a port and nobody has mentioned numbing cream to you, it is worth asking about.

Living With a Port Day to Day

One of the biggest practical advantages of a port is what happens between treatments. Unlike external catheters that dangle from your body and require daily care, a port lives entirely under the skin. Once the access needle is removed, there is nothing outside your body to protect, bandage, or keep dry. You can shower, swim, and exercise normally once the surgical site has fully healed. There is no tube to accidentally snag on clothing or doorknobs.

Between uses, though, the port still needs periodic flushing to prevent a clot from forming inside the catheter and blocking it. How often this needs to happen varies by institution, but a common schedule is every four to six weeks when the port is not actively being used. During a flush visit, a nurse accesses the port, pushes a syringe of fluid through it, and removes the needle. The visit typically takes only a few minutes.

The traditional flushing solution was heparin, a blood thinner. But multiple systematic reviews and meta-analyses have found that plain saline works just as well at keeping ports open. A meta-analysis pooling data from eight studies found no meaningful difference in patency between heparin and normal saline for central venous catheters.10PubMed Central. Heparin flush vs. normal saline flush to maintain the patency of central venous catheter among adult patients: A systematic review and meta-analysis Another study focused specifically on implanted ports confirmed that eliminating heparin did not increase blockage rates.11PubMed. Implanted Port Patency: Comparing Heparin and Normal Saline A third review recommended saline as a safe and effective replacement for heparin in port flushing.12PubMed. Heparin versus 0.9% saline solution to maintain patency of totally implanted venous access ports in cancer patients: A systematic review and meta-analysis This matters because heparin carries a small risk of side effects, including a rare but serious reaction called heparin-induced thrombocytopenia. Many cancer centers have already switched to saline-only flushing protocols, though some still use heparin out of tradition. If your center still uses heparin, the evidence suggests asking about saline is reasonable.

Risks and Complications

Ports have a good safety track record, particularly compared to other central venous access devices, but they are not risk-free. The complications worth knowing about fall into a few categories.

Infection is the concern that gets the most attention. In a large retrospective study of 566 cancer patients with ports undergoing chemotherapy, bloodstream infections were identified in about 7% of patients over the follow-up period. The most common culprits were Staphylococcus species, which accounted for the majority of infections, with Candida (a type of yeast) responsible for about a fifth of cases.13PubMed Central. Predictors of central line-associated bloodstream infections in cancer patients undergoing chemotherapy through implanted venous access ports Some port infections can be treated with antibiotics while the port stays in place, but severe infections sometimes require port removal. Strict sterile technique during every access is the single most important preventive measure.

Clotting and fibrin sheath formation are more common than many patients realize. As soon as a foreign object sits inside a blood vessel, the body begins coating it with a thin layer of protein called a fibrin sheath. One imaging study of cancer patients with ports found fibrin sheaths in about 16% of patients and catheter-associated blood clots in about 18%. These were often missed on routine CT scans, being unnoticed in roughly a fifth of examinations where they were present.14PubMed Central. Long-Term Follow-Up and Clinical Relevance of Incidental Findings of Fibrin Sheath and Thrombosis on Computed Tomography Scans of Cancer Patients with Port Catheters Many fibrin sheaths and small clots cause no symptoms at all, but they can occasionally block the catheter or cause swelling in the arm or neck. If a port stops drawing blood smoothly or infusions become sluggish, a fibrin sheath is often the reason. Thrombolytic drugs (clot-busting agents) instilled into the catheter usually resolve the problem without requiring port removal.

Catheter migration is uncommon but worth mentioning because its causes are surprisingly mundane. The catheter tip can shift position over time, potentially moving into a smaller vein or even, in rare cases, into an unintended location. Activities that change pressure inside the chest, such as heavy coughing, straining, or intense physical exertion, are thought to contribute.15PubMed Central. Spontaneous migration of a port catheter tip to the pulmonary vein: A case report of an uncommon complication A migrated catheter can usually be repositioned or, if necessary, replaced.

How Ports Compare to PICCs

The main alternative to a port for medium- to long-term IV access is a peripherally inserted central catheter, or PICC line. A PICC is a long thin tube inserted through a vein in your arm and threaded to the same central position as a port catheter. Unlike a port, a PICC line exits the skin and hangs externally, requiring daily flushing, dressing changes, and careful attention to keep it dry and uninfected. PICCs are cheaper to place upfront and do not require a surgical pocket, which makes them appealing for shorter treatment courses.

But for longer treatment regimens, ports tend to fare better. Multiple meta-analyses comparing the two in cancer patients have reached a consistent conclusion: ports are associated with fewer overall complications. One meta-analysis found that PICCs had higher rates of catheter-related blood clots and overall adverse events compared to ports.16PubMed Central. Peripherally inserted central catheters versus implantable port catheters for cancer patients: a meta-analysis A separate meta-analysis focused on gynecological cancer patients found that ports had fewer total complications, substantially less catheter malfunction (under 1% for ports versus over 4% for PICCs), and fewer clotting events.17PubMed Central. Peripherally Inserted Central Venous Catheters versus totally implantable venous access device for chemotherapy administration: a meta-analysis on gynecological cancer patients A 2025 meta-analysis based on randomized trials confirmed the pattern, finding more total complications, thrombosis, deep-vein clots, implantation failures, and unplanned catheter removals in the PICC group. Ports did, however, have a higher rate of pocket-site infections and more pain at the implantation site, which is the expected tradeoff of having a surgically created pocket.18PubMed Central. Implantable Port Catheters versus Peripherally Inserted Central Catheters for Cancer Patients Requiring Chemotherapy: An RCT-Based Meta-Analysis

From a cost perspective, ports require more money upfront for the device and the procedure, but economic evaluations have generally favored them over the life of a treatment course. One cost analysis of breast cancer patients found that total per-patient costs were lower with a port than with a PICC, largely because PICCs required more maintenance visits, more complication management, and more unplanned replacements.19Value in Health. Medico-economic evaluation comparing port catheters and peripherally inserted central catheters in adjuvant chemotherapy for breast cancer A broader systematic review echoed this, noting that ports were the more cost-effective option overall.20PubMed. Totally implanted ports and peripherally inserted central catheters for chemotherapy: a systematic review and meta-analysis of clinical outcomes and economic evaluations

Power-Injectable Ports and CT Scans

If you need regular contrast-enhanced CT scans, which many cancer patients do, a power-injectable port can save you a lot of peripheral IV sticks. Standard ports are not rated for the high pressures generated by contrast power injectors, but power-injectable ports are built to handle them. These devices are identified by distinctive markings visible on X-ray so the radiology team can confirm the port is safe for power injection before proceeding.

Studies of power-injectable ports during CT scanning have found them to be quite safe. In one series, 119 contrast injections through ports produced no extravasation or device failures.21PubMed. Practical use of the central venous access port for contrast-enhanced CT: comparison with peripheral intravenous access regarding enhancement and safety Another study tracked 142 port-based contrast injections during CT scans and likewise observed no extravasation or device failure, finding results comparable to other venous access methods.22PubMed. Power-injectable ports: safety during placement, therapeutic use, and contrast administration during computed tomography procedures If you know your treatment plan includes frequent imaging, asking about a power-injectable port at the time of placement can spare you repeated searches for a usable arm vein months down the road.

Ports in Children

Children with cancer or other conditions requiring long-term IV access are among the most frequent port recipients, and the devices work well in pediatric patients despite the obvious challenges of smaller anatomy. One pediatric series involving 64 patients (median age just over three years) reported a complication rate of about 9%, with infection being the most common issue, followed by malfunction and blockage.23PubMed Central. Port-a-Cath Insertion in Pediatric Patients With Malignancy in Tabuk Another study of radiologically placed ports in children reported a 100% technical success rate for implantation with no procedural complications such as pneumothorax, symptomatic clots, or catheter misplacement. The confirmed infection rate was 14%, or 0.04 per 100 access days, meaning infections were infrequent relative to how often the ports were used.24PubMed. Radiologic placement of implantable chest ports in pediatric patients A separate pediatric oncology series similarly reported an infection rate of 2.7% and a 0% procedural complication rate, noting that malfunctions from partial catheter clotting could be cleared with thrombolytic drugs without removing the port.25PubMed. Radiological placement of chest ports in pediatric oncology patients

For families, the daily-life advantages of a port are arguably even more pronounced than for adults. A toddler with a PICC line needs the exit site kept dry and protected, and a curious child pulling at an external catheter can create an emergency. A port eliminates these worries. Between treatments, a child with a port can take baths, splash in a pool, and tumble around a playground without any special precautions once the site has healed. The needle access moments can be stressful, especially for younger children, but the topical numbing creams discussed earlier go a long way toward managing that.

When a Port Gets Removed

Ports are designed to stay in for years if needed, but they are not permanent. Once treatment ends and your medical team determines the port is no longer needed, it is taken out in a short outpatient procedure, generally under local anesthesia. The surgeon reopens the pocket incision, disconnects the catheter from the port, pulls the catheter out of the vein, and removes the reservoir. The wound is closed and typically heals with a small scar. Most people report the removal is quicker and less uncomfortable than the original placement.

Deciding when to remove it is not always straightforward. Some people finish chemotherapy but have a meaningful chance of needing more treatment later, and replacing a port is a bigger deal than simply flushing an existing one every few weeks. Oncologists will sometimes recommend keeping a port in place for six months to a year after treatment ends as a precaution. Others prefer to remove it sooner, especially if the patient finds the bump cosmetically bothersome or psychologically tied to their illness. There is no universal timeline, and the conversation is worth having with your care team once you reach the end of active treatment.

The flushing orientation of the needle during each maintenance visit may seem like an insignificant detail, but it turns out to matter. Research on the internal fluid dynamics of ports found that pointing the Huber needle opening away from the catheter exit channel significantly improved how thoroughly the flush cleared residual material from the port chamber.26PubMed Central. Flushing ports of totally implantable venous access devices, and impact of the Huber point needle bevel orientation: experimental tests and numerical computation A cleaner flush means less residual blood or drug sitting inside the device between uses, which theoretically reduces the risk of occlusion or bacterial growth. It is a small technical point, but one that nurses trained in port care should be aware of.